Wireless Cardiac Monitoring Systems Market (2023 - 2030)

Wireless Cardiac Monitoring Systems Market Summary

The global wireless cardiac monitoring systems market size was valued at USD 2.98 billion in 2022 and is projected to reach USD 7.12 billionby 2030, growing at a CAGR of 11.4% from 2023 to 2030. Wireless cardiac monitoring systems are remote healthcare devices that track heart activities for medical analysis.

The market is expected to grow due to several factors, such as a growing geriatric population susceptible to cardiovascular diseases (CVDs), technological advancements in remote monitoring technologies, and increasing product approvals in developed economies. According to British Heart Foundation, the prevalence of heart & circulatory disease globally was 620 million in 2021, of which atrial fibrillation had a share of approximately 10%.

The pandemic had a positive impact on the market. According to an article by the European Society of Cardiology, mobile-based home electrocardiogram (ECG) monitoring systems enabled healthcare professionals to identify disease-related cardiac complications & ECG alterations in non-hospitalized COVID-19 patients. Moreover, patch-based monitoring systems gained FDA approval for inpatient monitoring of COVID-19 patients owing to a high prevalence of cardiovascular complications such as arrhythmias in hospitalized patients. In addition, the pandemic accelerated the demand for telehealth & virtual healthcare solutions, as patients had limited access to care facilities, which further boosted the market growth.

The advancements in remote patient monitoring technology are expected to boost the market. A growing number of industry players are entering into strategic alliances such as funding and collaboration to develop vendor-neutral cardiac data management platforms, which allows the company to monitor medical information from implantable cardiac monitors (ICM), wearable devices, consumer ECG devices, and others.

In addition, the introduction of artificial intelligence (AI) in the platform integrates electronic health records and identifies urgent patient reports and heart rhythm criticality. For instance, in July 2023, PaceMate, a remote cardiac monitoring service provider, received investment from Lead Edge Capital to alleviate the former company’s cardiac solutions and demographic reach. Such developments are expected to drive the market during the forecast period.

The growing prevalence of cardiovascular diseases and the increasing geriatric population susceptible to such diseases is expected to boost the market. According to American Heart Association, the age-adjusted prevalence of cardiovascular disease (CVD) was 7,354.1 per 100,000 population across the globe in 2020. Moreover, a similar source stated that more than two-thirds of the geriatric population is suspected of developing cardiovascular disease. According to Frontiers Media S.A. article, the prevalence of atrial fibrillation (AFib) increases with aging. As per a similar source, the prevalence of AFib in people aged 49 or below is 0.12% to 0.16%; however, in those aged 60 or above, the prevalence of AFib is estimated at 3.7% to 4.2%.

Type Insights

Based on type, the market is segmented into implantable cardiac monitors (ICM), patch-type monitors, mobile cardiac telemetry system, and others. Mobile cardiac telemetry systems dominated the market with a revenue share of 35.78% in 2022. These systems continuously monitor cardiac activities, improving diagnosis and patient compliance. In addition, medical professionals are actively integrating telemedicine into general practices, which allows them to analyze long-term patient heart rhythm activities and deliver patient-centric solutions via mobile cardiac telemetry.

The patch-type monitor segment is estimated to be the fastest-growing, with a CAGR of 13.2% during the forecast period. Patch-type monitors are non-invasive and are attached to the patient’s skin using adhesives. In addition, these devices are more discreet and convenient than traditional holter devices. A growing player participation in this category is expected to drive the growth of wireless cardiac monitoring systems growth. For instance, in October 2022, Turtle Shell Technologies Pvt Ltd announced to launch an ECG patch, which will allow healthcare professionals to identify early signs of cardiac disease or conditions to improve patient safety.

End-Use Insights

Based on end-use, the market is segmented into hospitals & clinics, diagnostic centers, and others. Hospitals & clinics dominated the market with a revenue share of 45.8% in 2022. The share is due to the hospital and clinic’s ability to manage patients who often require continuous cardiac monitoring due to their critical conditions. Moreover, these healthcare providers are equipped with nuanced medical equipment and specialized staff that facilitates the usage and diagnosis of wireless cardiac monitoring systems.

However, the diagnostic centers segment is estimated to be the fastest-growing, with a CAGR of 13.0% during the forecast period. The growing focus on outsourcing monitoring activities to independent facilities aids segment growth. For example, independent diagnostic testing facilities (IDTF) are specialized facilities with expertise in diagnostic testing, including cardiac monitoring. In addition, these facilities are increasing their collaboration with healthcare providers, further strengthening their growth. For instance, in December 2021, AliveCor, Inc. launched AliveCor Labs, an IDTF, to facilitate U.S. healthcare providers to access improved cardiac monitoring services.

Regional Insights

North America dominated the global wireless cardiac monitoring systems market and accounted for 48.53% of the total market share in 2022. The share is attributed to the advanced healthcare infrastructure, high prevalence of cardiovascular diseases, rapid technological advancements, high healthcare expenditure, and a growing geriatric population. According to Rural Health Information Hub, the geriatric population in the U.S. is expected to increase by 18 million between 2020-2030. Moreover, a similar source stated that 90% of adults over 65 develop one or more chronic conditions.

Asia-Pacific is expected to witness the fastest CAGR of 13.5% over the forecast period. The growth can be attributed to the increasing product approvals in countries such as China and Japan. For instance, in January 2020, Biotronik SE & Co. KG launched its implantable cardiac monitor (ICM), BioMonitor III, in Japan to help healthcare professionals identify underlying arrhythmia. Similarly, in October 2021, Shanghai Chest Hospital launched ICM to improve ECG monitoring & symptom correlation for Chinese patients. Such developments are expected to drive the growth of the market during the forecast period.

Key Companies & Market Share Insights

The market is highly competitive, with a large number of manufacturers, the market players are focusing on various strategic initiatives such as new product launches, geographical expansion, mergers and acquisitions, collaboration, product upgradation, and partnerships. For instance, in May 2023, VivaLNK, Inc. launched an updated multi-parameter wearable ECG patch. The product is expected to provide continuous 14-day live stream capabilities, which improve patient comfort and reduces the clinic’s administrative tasks. The following are some of the key manufacturers in the global wireless cardiac monitoring systems market:

• Koninklijke Philips N.V.

• Abbott

• Medtronic

• Biotronik SE & Co. KG

• Boston Scientific Corporation

• Asahi Kasei Corporation.

• iRhythm Technologies, Inc.

• Avertix Medical, Inc.

• Baxter International Inc.

• OSI Systems, Inc. (Spacelabs Healthcare)

Wireless Cardiac Monitoring Systems Market